The conversion of L-[U-14C]lysine into carnitine was demonstrated in normal, cholinedeficient and lysine-deficient rats. In other experiments in vivo radioactivity from L- [4,5-3H] lysine and DL-[6-14C]lysine was incorporated into carnitine; however, radioactivity from DL-[1-14C]lysine and DL-[2-14C]lysine was not incorporated. Administered L-[Me-'4C]methionine labelled only the 4-N-methyl groups whereas lysine did not label these groups. Therefore lysine must be incorporated into the main carbon chain of carnitine. The methylation of lysine by a methionine source to form 6-N-trimethyl-lysine is postulated as an intermediate step in the biosynthesis of carnitine. Radioactive 4-Ntrimethylaminobutyrate (butyrobetaine) was recovered from the urine of lysine-deficient rats injected with [U-14C] lysine. This lysine-derived label was incorporated only into the butyrate carbon chain. The specific radioactivity of the trimethylaminobutyrate was 12 times that of camitine isolated from the urine or carcasses of the same animals. These data further support the idea that the last step in the formation of carnitine from lysine was the hydroxylation oftrimethylaminobutyric acid, and are consistent with the following sequence: lysine+methionine -÷ 6-N-trimethyl-lysine 4-N-trimethylaminobutyrate -+ carnitine.
The ability of animal tissues to synthesize camitine (3-hydroxy-4-N-trimethylaminobutyrate) was recognized many years ago. Fraenkel (1953) showed that carnitine content in the chick embryo increased severalfold during development. Methionine was the first compound shown to be involved in carnitine biosynthesis. Methyl-labelled methionine was slowly incorporated into the N-methyl groups of camitine by the rat (Bremer, 1961; Strength et al., 1965; Wolf & Berger, 1961) , but the methyl acceptor was not determined. 4-Aminobutyrate was believed a likely precursor but its conversion into carnitine could not be demonstrated in the rat or mouse (Bremer, 1962; Lindstedt & Lindstedt, 1965) . In the rat hydroxyproline, threonine, ornithine, acetate and glucose were not converted into camitine (Wolf & Berger, 1961) , and in the mouse 5-N-trimethylaminopentanoate or 6-N-trimethylaminohexanoate were not converted into carnitine (Lindstedt & Lindstedt, 1965) . In mice, however, Lindstedt & Lindstedt (1965) found rapid hydroxylation of 4-N-trimethylaminobutyrate (butyrobetaine) to form carnitine; this reaction was catalyzed by the enzyme trimethylaminobutyrate (butyrobetaine) hydroxylase present in the soluble fraction of rat liver homogenates (Lindstedt, 1967) .
Lysine was first shown to be a precursor of carnitine in lysine auxotrophs of Neurospora crassa Home & Broquist, 1973) ; later, lysine was demonstrated to be a precursor of Vol. 136 carnitine in the rat Tanphaichitr & Broquist, 1973) . In the present study the role of lysine and methionine in the biosynthesis of carnitine was further defined. Lysine was found to be incorporated into both carnitine and 4-N-trimethylaminobutyrate in the rat and the results were consistent with the following sequence: lysine+ methionine -+ 6-N-trimethyl-lysine 4-N-trimethylaminobutyrate -* carnitine. The 4-N-trimethylaminobutyrate and 6-N-trimethyl-lysine and their radioactive derivatives were synthesized as described by Cox & Hoppel (1973) .
Materials and Methods Materials
L-[U-_4C]Lysine, DL-[6-1'4C]lysine, DL-[4,5-3H] lysine, L-[Me-
Animals
Male weanling rats of the Wistar strain weighing (45-55 g) were obtained from Carworth Farms, New City, N.Y., U.S.A. The animals were housed in wire bottom cages and fed on either Purina Lab Chow, the lysine-deficient diet, or the choline-deficient diet for the periods described. All rats were given radioactive substances by intraperitoneal injection in a solution of 0.9% NaCl neutralized with NaHCO3. Rats maintained on the special diets were injected with the radioactive compounds in equal doses once daily for 4 days, and were then killed on the fifth day.
Isolation of carnitine
Carnitine was extracted by a modification of the method of Pearson & Tubbs (1964) . The rats were killed by decapitation, and the carcasses prepared by removing the skin, feet, tail and intestinal tract. The remains were then homogenized and extracted twice with 5% (w/v) HCI04 (total 6m1/g wet wt. oftissue). After the removal of the protein precipitate, the supernatant was adjusted to pH 13 with saturated KOH and kept at room temperature for 1 h to hydrolyse the acid-soluble acylcarnitines. After neutralization with 70 % (w/v) HC104 the extract was cooled in ice for at least 1 h and then centrifuged. The camitine was further purified by one of two procedures: method I or method II.
Method L The neutralized extract was freeze-dried; the residue was extracted with water and acidified to a pH of less than 3.0 with conc. HCI. The acid extract (15-20ml) was chromatographed through a jacketed column (1 cm x 50cm) of resin AG-50 (X8; Na+ form) at 50°C, eluted with a citrate buffer gradient described by Piez et al. (1956) and modified by Home et al. (1971) ; the mixing flask contained citrate buffer, pH4.1 (0.25M-Na'), and the reservoir contained 0.25M-NaOH. The effluent was collected in 2ml fractions. As shown in Fig. 1 (Wall et al., 1960) , and trimethyllysine was determined by the ninhydrin assay (Moore & Stein, 1954) .
(1.Scmxl0cm) of resin AG-1 (X8; OH-form) eluted with water. The fractions containing carnitine were desalted on a column (1 cm x 50cm) of resin AG-1I A8 eluted with water or with a column (1cm x 50 cm) of resin AG-50 (X8) eluted with 1.5M-HCI.
Method I. In this method the resin AG-1 column adsorption was carried out before the extract was chromatographed on the AG-50 citrate buffer column. The neutralized extract (approx. 500ml) was passed through a column (2.5 cmx 12 cm) of AG-I (X8; OH-form) and washed through with 50ml of water. The effluent was acidified with HCl and freeze-dried; this material was extracted with 5 x 20ml of hot ethanol, and the ethanol removed by evaporation. The resultant residue was taken up in 5 ml of water and chromatographed through an AG-50 (X8) column eluted with citrate buffer as described in method I. The carnitine fractions were desalted by using a column (1 cm x 50cm) of AG-50 eluted with 1.5M-HCI. On the desalting column, citrate was eluted in the first 60ml and carnitine in 110-125ml. Radioactivity was measured by using a Packard Tri-Carb Model 3375 liquid-scintillation spectro-1973 meter. Samples were diluted to 0.5-1.Oml with water and counted for radioactivity in 10ml of scintillant composed of 16.7g of 2,5-diphenyloxazole, 0.17g of 1,4 bis-(4-methyl-5-phenyloxazol-2-yl)benzene, 667ml of toluene and 333 ml of Triton X-100. Camitine was assayed enzymically by the method of Marquis & Fritz (1964) .
Thin-layer chromatography The carnitine which had been purified from each experiment was subjected to t.l. (200,ug) to detect contaminants and determine the amount of radioactivity present. The solvent front was allowed to run 15cm from the origin. Compounds were detected by spraying the plates with 1 % (w/v) I2 in ether followed by either 0.5 % (w/v) ninhydrin in butanol or iodoplatinate (Sunshine, 1969) . The chromatograms were cut into 1 cm strips, which were counted for radioactivity in scintillant vials with 1 ml of water and 10ml of the Triton-toluene scintillant.
Deamination of carnitine and 4-N-trimethylaminobutyrate
The amount of radioactivity in the 4-N-methyl groups ofcarnitine was determined by deamination in base, and the evolved trimethylamine was trapped in 1.5M-HCI (Wolf & Berger, 1961) . The 1.5M-HCI trap was evaporated to dryness in vacuo and the trimethylamine hydrochloride was precipitated with 4% (w/v) chloroplatinic acid in ethanol. The trimethylamine-chloroplatinate precipitate was collected by centrifugation, washed with 5ml of cold ethanol, and dried at 100°C in vacuo. A portion (5-10mg) of the precipitate was weighed into a counting vial, dissolved in 1 ml of water and radioactivity was determined. The total amount of radioactivity in the methyl groups of carnitine was calculated from the specific radioactivity of the trimethylamine-chloroplatinate complex. Similar methods were used to deaminate trimethylaminobutyrate, except that the radioactive compound plus carrier were boiled for 1 h in 50% (w/v) NaOH instead of 10% (w/v) NaOH. Vol. 136
Results

Development of methods
A sufficient amount of tissue (50-200g wet wt.) was extracted to obtain enough carnitine for further studies. In a preliminary experiment an AG-50 column, eluted with the citrate buffer system, did not adequately separate carnitine from other lysinelabelled compounds. When an acid extract from animals injected with [U-14C]lysine was chromatographed through the AG-50 citrate buffer column, one of the radioactive peaks corresponded to the fractions containing carnitine. However, when these fractions were desalted and chromatographed on t.l.c. two radioactive spots were detected. Most of the radioactivity (80%) chromatographed on silica gel with carnitine (solvent system C; RF= 0.30); the remaining 20 % was associated with a compound detected only with the ninhydrin spray (RF= 0.55).
No carrier carnitine was added to the samples before t.l.c.
A second column chromatography step was then used to purify carnitine further. The anion-exchange resin AG-1 (OH-form) binds most amino acids, including lysine, but excludes quaternary amines such as carnitine, trimethylaminobutyrate and trimethyl-lysine. Therefore carnitine fractions from the AG-50 citrate buffer column were washed through a column ofresin AG-1 and desalted (method I). In the desalted fraction all radioactivity cochromatographed with carnitine in the four t.l.c. systems, and no ninhydrin-positive material was detected. A minor non-radioactive contaminant was found with the 12 spray in some cases. After the addition of carrier the radioactive camitine was crystallized six times from ethanol without change in specific radioactivity. Since the compounds of primary interest were excluded from the AG-1 resin, this adsorption procedure was carried out before chromatography on the AG-50 resin citrate buffer column (method II). The AG-50 chromatogram of Fig. 2(c) shows that prior adsorption with AG-1 resin eliminates any overlap by other radioactive compounds into the carnitine peak (cf. Figs. 2a and 2b) .
Conversion of uniformly labelled lysine into carnitine
The conversion of lysine into carnitine in vivo was shown in normal, choline-deficient and lysinedeficient rats (Table 1) . When a rat fed on a normal diet was given [U-14C]lysine (Fig. 2a) (Strength et al., 1965) . Thus two choline-deficient rats were given L-[U-14C]lysine daily for 4 days at about the same dose as was given to normal rats. Carnitine isolated from these animals had a specific radioactivity of 570 d.p.m./,umol (Fig. 2b) .
Acute choline supplementation increased the concentration of carnitine in the tissues of cholinedeficient rats (Corredor et al., 1967) Because the lysine-deficient and choline-deficient states led to higher specific radioactivity of carnitine after the injection of labelled lysine, both of these models were used in further studies.
Conversion ofspecifically labelled lysines into carnitine
Having established that [U-14C]lysine was converted into carnitine, we used specifically labelled lysines to determine which carbon fragment was the actual precursor. Camitine isolated from cholinedeficient rats given DL-[6-14C]lysine had a specific radioactivity of 260d.p.m./,umol, and the carnitine isolated from animals given L-[4,5-3H]lysine had a specific radioactivity much higher than would be expected for non-specific chemical exchange ofhydrogen atoms (Table 2) . However, no significant label could be found in camitine after the administration of DL-[1-14C]lysine or DL-[2-14C]lysine (Table 2) . Thus in choline-deficient animals the C4, C-5 and C-6 oflysine were incorporated into camitine, whereas C-1 and C-2 were not incorporated.
Deamination ofcarnitine
Camitine from the rats injected with [U-14C]lysine or [6-14C] lysine was deaminated to determine if the lysine label was incorporated into the 4-N-methyl groups of the main carbon chain. The deamination liberated the methyl groups as trimethylamine, which was precipitated as the chloroplatinate, and its specific radioactivity was determined. No significant amount of radioactivity was found in the liberated trimethylamine (Table 3) whereas reference [Me-14C]carnitine gave 95-105% recovery of label in the methyl groups and [carboxy-14C]carnitine yielded 0%. Therefore label from lysine must be present in the main carbon chain of carnitine.
Methionine and lysine asprecursors ofcarnitine
The contributions of methionine and lysine to carnitine biosynthesis were determined simultane-1973 -(c) Fig. 2(a) ; Expt. B, further details are given in Fig. 2(b) ; Expt. C, the carnitine was extracted from the carcasses of two rats (145g and 140g) which were kept on a choline-deficient diet for 60 days. These animals were injected daily with 70,umol of choline chloride/1OOg during the last three days of administering radioactive lysine. Expt. D, further data in Fig. 2(c Fig. 2(b) ; Expt. B, further details given in Table 1 (Expt. C). Expt. C, further details given in Table 2 ; Expt. D, details given in Fig. 2(c) ; Expt. E, details given in Fig. 2(a) . (Fig. 3) (Table 4) . A similar experiment was done by using choline-deficient rats injected with [4,5-3H] lysine and [Me-14C]methionine. Carnitine purified from these animals was subjected to demethylation and again only methionine label wasincorporatedintothe4-N-methylgroups(Table4). Table 4 . Source ofthe main carbon chain andmethylgroups ofcarnitine Expt. A, carcasses were combined from two rats (198g and 182g) which were kept for 50 days on the choline-deficient diet. Expt. B, carcasses were combined from two rats (52 g and 57 g) which were kept on the lysinedeficient diet for 24 days (see also Fig. 3 Table 4 . A, 3H Radioactivity; U, 14C radioactivity; 0, carnitine.
Conversion of lysine into 4-N-trimethylaminobutyrate
Trimethylaminobutyrate (butyrobetaine) was not isolated from carcass extracts of animals given radioactive lysine since only a small amount of radioactivity was present in the area where trimethylaminobutyrate was eluted from the AG-50 resin citrate buffer column. In contrast with the findings of Tanphaichitr & Broquist (1973) , a significant amount of radioactive trimethylaminobutyrate was recovered from the urine of lysine-deficient rats injected with [U-14C] lysine. This urinary 4-trimethylaminobutyrate was iodoplatinate-positive and ninhydrin-negative and chromatographed on cellulose t.l.c. plates (system A) in a manner identical with synthetic 4-trimethylaminobutyrate (RF = 0.5). The Table 5 . Conversion of labelled lysine into carnitine and 4-trimethylaminobutyrate Labelled metabolites were isolated by method II from two weanling rats which had been maintained for 27 days on a lysine-deficient diet and then injected with 84.5,uCi of L-[U'4C]lysine/l00g daily for the last four days. The urine was collected daily into 1 ml of 0.1 M-HCl, and the four samples were pooled. To determine the specificradioactivity oftrimethylaminobutyrate in the urine, the appropriate citrate buffer column fractions were desalted, and approx. 15,ug of trimethylaminobutyrate was further purified by t.l.c. on cellulose by using solvent system A. The compound was eluted from the t.l.c. plate with 0.5 ml of 1.OM-HC1 and assayed by the periodide reaction (Wall et al., 1960) . After dissolving the periodidequaternary amine precipitate in ethylene dichloride, a portion was determined spectrophotometrically with 4-trimethylaminobutyrate as a standard, and radioactivity was also determined on a portion. 
Discussion
When rats were given radioactive lysine, the carnitine isolated from animals raised on diets deficient in lysine or choline had a much higher specific radioactivity than the carnitine recovered from animals fed on a normal diet. In choline deficiency this would be expected, since the turnover of carnitine is increased, and there is a decreased body pool of carnitine (about half that in control rats) which would dilute newly synthesized carnitine to a smaller extent (Mehlman et al., 1971) . The amount of carnitine extracted from the carcasses of rats fed on a lysinedeficient diet was one-quarter lower than from normal animals ( Table 1) ; nothing is known about the turnover of carnitine under these conditions. However, other changes in lysine metabolism have been observed during lysine deficiency. After 1 week on a lysine-deficient diet, rats metabolized [U-14C]lysine to C02, blood sugar, glycogen and lipid at one-half the rate in normally fed rats, yet the incorporation of labelled lysine into liver protein was almost doubled (Yamashita & Ashida, 1969) . This latter point may be significant, since the only known route of 6-Ntrimethyl-lysine synthesis (a proposed intermediate in carnitine biosynthesis) is via the methylation of protein-bound lysine by S-adenosylmethionine (Paik & Kim, 1971) .
Earlier investigations in rats could not establish lysine as a precursor of carnitine (Wolf & Berger, 1961) . In a normally fed rat we recovered 0.005 % of the administered L-[U-14C]lysine in the carcass carnitine, in choline-deficient rats the recovery in carnitine was 0.014%, and in the lysine-deficient animals it was 0.026 %. Considering this low conversion, it is not surprising that Wolf & Berger (1961) did not demonstrate incorporation of radioactive lysine into carnitine when they injected rats with only 0.9,uCi of [U-4C]lysine/100g body wt. in a shorter term (24h) experiment.
Our findings demonstrated that C-4, C-5 and C-6 of lysine were converted by the rat into carnitine, but C-1 and C-2 were not. Similar findings have been reported by Tanphaichitr & Broquist (1973) . Further, the lysine label in carnitine was not in the 4-N-methyl groups and therefore was part of the main carbon chain. The studies with both labelled lysine and methionine showed that carnitine was synthesized by the addition ofmethyl groups from methionine to a carbon chain originating from lysine. It may be that lysine itself was the methyl-group acceptor, and methionine entered the pathway of carnitine biosynthesis at the level of 6-N-trimethyl-lysine synthesis. This would be consistent with the following sequence: lysine+methionine -* 6-N-trimethyl-lysine 4-Ntrimethylaminobutyrate -÷ carnitine.
Trimethylaminobutyrate, a proposed intermediate in the above scheme, has been identified in human and dog urine (Broekhuysen & Deltour, 1961) and was rapidly hydroxylated to form carnitine in the rat (Lindstedt & Linstedt, 1961) . This reaction was found to be catalysed by a hepatic enzyme, 4-trimethylaminobutyrate (butyrobetaine) hydroxylase, which showed a high degree of substrate specificity (Lindstedt, 1967) . Trimethylaminobutyrate has been established as a metabolite of 6-N-trimethyl-lysine in yeast (Home & Broquist, 1973) and in the rat (Cox & Hoppel, 1973; Tanphaichitr & Broquist, 1973) . We have demonstrated that its four-carbon chain is derived from lysine. After the administration of radioactive lysine, 4-trimethylaminobutyrate was found to have a higher specific radioactivity than camitine. This is consistent with a precursorproduct relationship for these compounds and further supports the scheme ofcarnitine biosynthesis outlined above.
